Home - Products - Tyrosine Kinase - Src - KX1-004

KX1-004

CAS No. 518058-84-9

KX1-004( KX1004 | KX 1004 | KX1-004 )

Catalog No. M14808 CAS No. 518058-84-9

KX1-004 is a potent small molecule inhibitor of Src-PTK as a potential protective drug for NIHL.

Purity : >98% (HPLC)

COA

Datasheet

HNMR

HPLC

MSDS

Handing Instructions

Size	Price / USD	Stock	Quantity
1 mL x 10 mM in DMSO	93	In Stock
2MG	51	In Stock
5MG	85	In Stock
10MG	155	In Stock
25MG	282	In Stock
50MG	456	In Stock
100MG	642	In Stock
200MG	Get Quote	In Stock
500MG	1349	In Stock
1G	Get Quote	In Stock

Get Quotation Bulk Inquiry Add to Cart

Biological Information

Product Name

KX1-004
Note

Research use only, not for human use.
Brief Description

KX1-004 is a potent small molecule inhibitor of Src-PTK as a potential protective drug for NIHL.
Description

KX1-004 is a potent small molecule inhibitor of Src-PTK as a potential protective drug for NIHL.
In Vitro

——
In Vivo

KX1-004 (30 μM) provides significant protection against noise-induced temporary threshold shift (TTS), permanent threshold shift (PTS) and outer hair cells (OHC) loss.KX1-004 (50 mg/kg) is effective against noise exposure.
Synonyms

KX1004 | KX 1004 | KX1-004
Pathway

Tyrosine Kinase
Target

Src
Recptor

Src-PTK
Research Area

Other Indications
Indication

——

Chemical Information

CAS Number

518058-84-9
Formula Weight

284.29
Molecular Formula

C16H13FN2O2
Purity

>98% (HPLC)
Solubility

DMSO: 10 mM
SMILES

O=C(C(N1)=CC2=C1C=CC(F)=C2)NCC3=CC=CC(O)=C3
Chemical Name

5-fluoro-N-(3-hydroxybenzyl)-1H-indole-2-carboxamide.

Shipping & Storage Information

Storage

(-20℃)
Shipping

With Ice Pack
Stability

≥ 2 years

Reference

1. Harris KC, et al. Hear Res. 2005 Oct;208(1-2):14-25.

Calculator

Molecular Weight Calculator

Dilution Calculator

Molarity Calculator

molnova catalog

related products

SBC-115076

SBC-115076 is a potent extracellular proprotein convertase subtilisin kexin type 9 (PCSK9) antagonist.
Lyn peptide inhibito...

Cell-permeable inhibitor of Lyn-dependent effects of the IL-5 receptor. Blocks binding of Lyn tyrosine kinase to βc subunit of IL-3/GM-CSF/IL-5 receptors, blocking Lyn activation. Inhibits IL-5 receptor-mediated eosinophil differentiation and survival in vitro. Inhibits airway eosinophilic inflammation in mouse model of asthma.
P7C3-A20

P7C3 is a drug related to latrepirdine (dimebon), which has neuroprotective and proneurogenic effects, and may be potentially useful for the treatment of Alzheimer's disease and similar neurodegenerative disorders.

Sign In Join Free